GO	[-9.50 -0.62]	[-0.62 -0.44]	[-0.44 -0.22]	[-0.22 -0.10]	[-0.10 -0.01]	[-0.01 0.00]	[0.00 0.06]	[0.06 0.16]	[0.16 0.34]	[0.34 0.87]	[0.87 15.11]
PUJANA_XPRSS_INT_NETWORK PUJANA_XPRSS_INT_NETWORK	-4.779	-4.004	-0.269	1.507	11.273	-3.355	1.076	4.345	-0.366	-1.926	-5.713
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	-3.765	-5.456	-0.301	2.868	5.149	-2.144	2.247	6.040	-0.409	-3.765	-5.439
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-4.203	-5.746	-0.829	3.160	3.160	-3.592	2.850	4.934	2.012	-2.597	-4.893
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-4.315	-3.645	0.261	3.895	6.354	-3.072	0.462	3.539	0.901	-1.466	-7.341
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-5.559	-3.437	-0.756	3.701	6.479	-2.917	0.342	4.054	1.904	-2.917	-3.421
WINNEPENNINCKX_MELANOMA_METASTASIS_UP WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-5.496	-2.628	-0.556	2.212	8.987	-3.799	1.430	2.511	0.822	-3.165	-3.151
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	-3.527	-3.527	-0.608	1.914	5.588	-4.267	-0.339	3.906	4.301	-2.397	-4.251
RAMALHO_STEMNESS_UP RAMALHO_STEMNESS_UP	-1.860	-4.947	-0.672	1.738	6.108	-4.236	1.299	4.501	1.510	-2.217	-4.928
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	-4.632	-2.224	-0.441	3.784	11.078	-2.686	-0.441	1.162	0.630	-1.201	-4.615
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-4.638	-3.761	-1.274	2.414	5.603	-3.060	-0.430	5.140	1.813	-0.767	-3.747
FUJII_YBX1_TARGETS_DN FUJII_YBX1_TARGETS_DN	-2.167	-3.561	-0.647	0.649	8.564	-3.032	1.144	4.987	0.797	-1.815	-5.689
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	-5.335	-4.525	-0.402	0.799	2.083	-3.840	2.956	3.620	2.083	0.514	-4.507
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-3.906	-6.401	0.285	1.533	4.626	-3.906	0.491	2.577	2.879	-0.318	-3.299
PUJANA_BRCA_CENTERED_NETWORK PUJANA_BRCA_CENTERED_NETWORK	-2.982	-2.982	-0.443	0.936	7.943	-2.351	0.735	4.765	-0.312	-1.432	-4.886
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	-4.350	-2.606	-1.807	1.971	3.157	-3.677	0.721	4.217	3.157	-0.354	-4.333
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-2.341	-4.194	-0.436	2.911	5.720	-3.460	1.457	1.457	0.827	-0.759	-5.088
WHITEFORD_PEDIATRIC_CANCER_MARKERS WHITEFORD_PEDIATRIC_CANCER_MARKERS	-3.752	-4.858	-0.598	3.925	5.320	-1.815	0.426	1.730	1.190	-2.947	-1.400
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	-3.676	-2.878	-0.567	3.617	4.976	-2.878	-0.567	4.502	0.452	-1.358	-2.247
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	-2.365	-3.107	-0.521	5.110	2.429	-1.798	1.164	0.921	1.740	-2.365	-4.139
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-2.962	-2.962	1.379	1.914	7.886	-3.653	0.580	0.745	0.320	-1.535	-2.384
LEE_LIVER_CANCER_SURVIVAL_DN LEE_LIVER_CANCER_SURVIVAL_DN	-2.634	-3.710	-0.270	1.941	4.946	-2.203	1.457	2.209	1.045	-1.508	-4.368
CROONQUIST_IL6_DEPRIVATION_DN CROONQUIST_IL6_DEPRIVATION_DN	-2.197	-1.650	-0.897	-0.447	7.896	-2.919	0.816	3.091	1.318	-2.197	-2.189
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-3.677	-3.102	-1.211	2.530	5.002	-2.178	0.451	1.264	3.494	-0.976	-2.593
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	-4.706	-3.936	-0.464	2.670	1.810	-1.877	1.118	2.670	2.670	-0.782	-3.277
KONG_E2F3_TARGETS KONG_E2F3_TARGETS	-2.994	-1.709	-0.940	2.577	4.831	-2.264	0.412	2.977	0.771	-1.278	-4.015
DAZARD_UV_RESPONSE_CLUSTER_G6 DAZARD_UV_RESPONSE_CLUSTER_G6	-0.834	-2.606	0.257	4.455	4.042	-5.984	0.795	1.431	0.257	-1.362	-2.594
DANG_MYC_TARGETS_UP DANG_MYC_TARGETS_UP	-3.404	-4.251	-0.321	1.864	3.598	-2.734	1.325	3.209	0.881	-1.369	-2.178
GOLDRATH_HOMEOSTATIC_PROLIFERATION GOLDRATH_HOMEOSTATIC_PROLIFERATION	-4.049	-3.326	0.903	3.449	2.744	-2.228	0.725	3.087	0.433	-1.807	-2.716
BENPORATH_PROLIFERATION BENPORATH_PROLIFERATION	-4.949	-4.049	0.319	2.420	2.116	-1.807	1.832	1.568	1.832	-0.904	-2.716
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	-1.659	-2.831	-0.714	4.197	2.258	-4.630	1.741	2.842	0.479	-0.898	-2.817
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	2.012	4.551	-1.260	-2.192	-4.203	3.160	-0.302	-1.528	-3.592	-0.302	1.547
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-2.914	-1.960	-1.276	1.649	3.906	-1.011	-0.339	2.827	2.503	-0.608	-5.166
PUJANA_BREAST_CANCER_LIT_INT_NETWORK PUJANA_BREAST_CANCER_LIT_INT_NETWORK	-1.381	-2.399	0.896	4.529	3.166	-4.192	-1.381	1.702	0.507	-0.752	-2.389
UDAYAKUMAR_MED1_TARGETS_UP UDAYAKUMAR_MED1_TARGETS_UP	-2.365	-3.617	-0.921	1.666	2.923	-3.617	1.948	2.252	1.666	-0.703	-2.354
KAUFFMANN_DNA_REPLICATION_GENES KAUFFMANN_DNA_REPLICATION_GENES	-2.698	-3.293	0.582	2.786	2.151	-4.013	1.126	1.351	1.126	0.329	-3.998
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-1.254	-4.059	0.458	2.045	5.715	-2.043	0.610	1.470	0.610	-2.573	-2.562
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	-1.756	-3.977	-0.667	2.187	3.178	-3.259	-0.371	4.763	1.150	-1.113	-1.398
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-3.177	-2.291	0.875	2.421	5.930	-4.336	0.721	1.234	-0.334	-0.712	-1.916
KAUFFMANN_MELANOMA_RELAPSE_UP KAUFFMANN_MELANOMA_RELAPSE_UP	-2.529	-1.677	-0.287	3.544	3.544	-2.529	0.315	2.540	-0.470	-1.122	-2.522
WHITFIELD_CELL_CYCLE_G2_M WHITFIELD_CELL_CYCLE_G2_M	-1.612	-1.335	0.270	3.006	4.355	-3.717	-0.334	3.006	0.875	-2.705	-2.691
WELCSH_BRCA1_TARGETS_UP WELCSH_BRCA1_TARGETS_UP	-3.779	-1.654	-0.458	1.009	4.261	-5.124	1.193	0.559	3.567	-0.586	-1.363
MISSIAGLIA_REGULATED_BY_METHYLATION_DN MISSIAGLIA_REGULATED_BY_METHYLATION_DN	-3.122	-1.533	0.254	1.850	8.139	-2.477	1.300	0.364	0.254	-1.186	-2.466
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	-2.657	-0.940	-0.568	1.184	6.846	-4.595	1.901	1.404	-0.568	-0.737	-1.793
VILLANUEVA_LIVER_CANCER_KRT19_UP VILLANUEVA_LIVER_CANCER_KRT19_UP	-3.580	-2.523	-0.570	2.953	5.595	-1.424	0.485	2.064	0.485	-1.155	-2.510
JISON_SICKLE_CELL_DISEASE_DN JISON_SICKLE_CELL_DISEASE_DN	-3.376	-2.021	0.736	1.962	4.912	-5.484	0.269	1.484	-0.335	0.593	-1.376
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-2.359	-3.906	0.285	1.533	1.533	-2.359	1.315	2.577	2.021	0.285	-4.577
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-3.652	-1.966	-0.522	1.264	5.040	-2.658	0.995	0.995	1.565	-1.053	-1.958
MORI_IMMATURE_B_LYMPHOCYTE_DN MORI_IMMATURE_B_LYMPHOCYTE_DN	-3.776	-1.534	-0.572	1.168	4.790	-2.065	1.168	0.914	1.772	-1.127	-2.761
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	-2.306	-4.405	-1.845	0.801	2.330	-2.864	0.351	2.019	4.196	0.351	-0.666
SMITH_TERT_TARGETS_UP SMITH_TERT_TARGETS_UP	-3.940	-3.226	0.777	1.656	-0.258	-2.145	-0.360	5.268	2.224	-0.360	-1.721
WHITFIELD_CELL_CYCLE_M_G1 WHITFIELD_CELL_CYCLE_M_G1	-2.043	-2.573	-0.538	6.748	3.468	-2.043	-0.963	0.990	0.610	-0.727	-1.601
LI_DCP2_BOUND_MRNA LI_DCP2_BOUND_MRNA	-1.966	-1.966	-0.351	-1.966	1.565	-2.658	0.390	4.006	1.565	2.263	-2.649
TIEN_INTESTINE_PROBIOTICS_6HR_DN TIEN_INTESTINE_PROBIOTICS_6HR_DN	-3.419	-2.863	0.318	4.634	1.236	-3.419	0.547	1.695	1.035	0.423	-2.373
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-2.172	-2.667	1.150	5.203	2.828	-2.667	-0.869	1.377	0.338	-2.172	-0.661
BROWNE_HCMV_INFECTION_14HR_UP BROWNE_HCMV_INFECTION_14HR_UP	-2.455	-3.595	-0.260	1.352	3.433	-2.455	-0.358	1.851	3.433	-1.636	-1.041
EPPERT_PROGENITOR EPPERT_PROGENITOR	-1.953	-1.231	-0.407	1.351	4.384	-2.994	0.310	2.495	1.880	-2.425	-2.414
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	-2.696	-3.693	0.736	0.376	2.214	-2.696	0.376	3.934	0.967	0.246	-1.991
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	-2.740	-2.740	1.363	0.251	2.284	-3.523	0.882	2.642	1.363	-0.357	-2.729
MATTIOLI_MGUS_VS_PCL MATTIOLI_MGUS_VS_PCL	-4.097	-1.635	-1.635	-0.282	1.191	1.440	2.327	3.031	0.768	-0.552	-4.084
MALONEY_RESPONSE_TO_17AAG_DN MALONEY_RESPONSE_TO_17AAG_DN	-1.144	-3.194	-0.355	1.350	3.338	-1.612	1.680	2.444	-0.355	-1.144	-3.185
REN_BOUND_BY_E2F REN_BOUND_BY_E2F	-1.712	-2.571	-0.301	2.949	1.284	-1.712	0.301	2.474	1.640	-1.712	-2.564
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-1.843	-2.351	0.291	5.747	3.050	-2.351	-0.613	0.561	1.163	-0.829	-2.340
CROONQUIST_NRAS_SIGNALING_DN CROONQUIST_NRAS_SIGNALING_DN	-1.999	-1.999	-0.647	-0.264	5.594	-2.903	0.519	2.012	1.636	-1.393	-0.956
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	-4.560	-1.327	-0.536	3.239	1.338	-3.284	-0.536	2.918	1.338	0.633	-1.605
ALCALA_APOPTOSIS ALCALA_APOPTOSIS	-3.610	-1.933	0.267	1.023	3.140	-1.933	1.023	0.267	3.596	-1.029	-1.926
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	1.635	3.622	-0.719	-1.926	-2.962	0.438	0.580	-3.653	-1.209	-0.539	3.640
LEE_EARLY_T_LYMPHOCYTE_UP LEE_EARLY_T_LYMPHOCYTE_UP	-1.214	-2.071	-1.214	0.542	3.544	-2.671	2.031	2.739	1.163	-2.671	-1.207
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	2.714	2.128	0.646	-1.691	-3.516	0.976	-2.051	-2.952	-1.691	0.976	2.142
GAVIN_FOXP3_TARGETS_CLUSTER_T7 GAVIN_FOXP3_TARGETS_CLUSTER_T7	-3.145	-2.399	-0.373	1.405	2.028	-1.828	0.507	1.136	3.596	-0.373	-3.134
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	-0.761	-3.072	0.462	2.002	3.895	-2.578	0.901	2.275	-0.595	-0.595	-3.629
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-2.145	-2.637	-1.731	1.656	5.729	-2.637	0.612	1.404	0.777	-0.490	-0.845
ELVIDGE_HYPOXIA_DN ELVIDGE_HYPOXIA_DN	-4.949	-3.326	-0.284	1.325	0.433	-1.452	0.568	3.087	2.744	0.319	-1.145
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-2.929	-3.617	0.330	1.948	2.923	-2.365	0.763	0.595	2.252	-0.384	-1.889
MEISSNER_NPC_HCP_WITH_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K27ME3	-0.383	3.202	-0.383	-1.675	-1.675	7.141	-0.244	-2.326	-1.198	-0.842	-0.242
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	-0.771	-1.747	-0.962	1.635	4.754	-4.070	0.845	2.406	0.436	-2.094	-0.954
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	-3.904	-1.706	-0.478	0.795	1.963	-1.706	0.257	3.272	3.272	-0.638	-2.106
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	-1.336	-3.485	-0.301	2.081	4.840	-1.836	0.301	1.402	0.451	-0.958	-1.828
BURTON_ADIPOGENESIS_3 BURTON_ADIPOGENESIS_3	-1.858	-3.183	-0.385	1.108	2.334	-2.432	0.346	3.109	1.665	-0.385	-2.423
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	-2.277	-3.291	0.468	1.118	2.992	-2.277	-0.608	2.078	1.560	0.754	-2.731
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-2.197	-2.197	-0.893	0.980	1.706	-0.893	0.691	4.932	0.272	-0.556	-2.191
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	-2.288	-2.288	-0.418	2.076	2.076	-2.913	-0.418	2.771	2.076	-0.582	-1.779
LIU_VMYB_TARGETS_UP LIU_VMYB_TARGETS_UP	-2.043	-0.538	-0.388	2.368	1.470	-4.059	-1.254	1.470	3.468	-0.388	-2.033
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	0.301	1.406	0.402	-1.100	-3.483	6.689	-0.301	-1.362	-2.026	-1.100	1.417
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	-2.280	-1.466	-0.365	0.637	2.473	-1.466	0.245	5.358	-0.365	-0.365	-2.274
LE_EGR2_TARGETS_UP LE_EGR2_TARGETS_UP	-2.101	-1.622	0.261	0.380	5.350	-2.705	-0.685	3.919	0.380	-0.685	-0.924
BASSO_B_LYMPHOCYTE_NETWORK BASSO_B_LYMPHOCYTE_NETWORK	-2.172	-4.871	1.377	1.897	1.626	-1.756	0.759	1.626	0.597	-0.371	-2.161
WHITFIELD_CELL_CYCLE_G2 WHITFIELD_CELL_CYCLE_G2	-1.951	-1.951	0.327	1.723	2.261	-3.387	1.983	1.055	1.723	-1.601	-1.939
WANG_CLIM2_TARGETS_DN WANG_CLIM2_TARGETS_DN	-3.223	-1.572	0.526	2.995	1.610	-1.901	0.662	3.322	0.309	-0.836	-2.704
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	-1.948	-1.191	-0.431	1.620	0.597	-1.948	-1.191	2.561	3.102	-0.242	-1.943
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	0.849	3.053	0.334	-1.888	-2.466	3.917	-0.270	-2.466	-2.466	0.334	0.338
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-2.288	-0.582	-0.418	4.435	3.986	-2.913	0.439	0.593	-0.291	-1.055	-1.779
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	-1.865	-1.865	-0.676	0.654	3.288	-1.865	0.654	1.320	1.736	-0.676	-1.860
WELCSH_BRCA1_TARGETS_DN WELCSH_BRCA1_TARGETS_DN	-2.515	-3.796	-0.442	0.676	2.068	-1.016	1.051	1.516	3.051	-0.442	-2.504
VERNELL_RETINOBLASTOMA_PATHWAY_UP VERNELL_RETINOBLASTOMA_PATHWAY_UP	-1.999	-1.999	-0.961	2.425	1.636	-1.999	1.297	2.012	0.997	-0.961	-1.992
RHODES_UNDIFFERENTIATED_CANCER RHODES_UNDIFFERENTIATED_CANCER	-0.935	-1.363	-1.963	0.539	3.950	-1.363	0.763	3.428	0.539	-1.363	-1.956
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-2.597	-1.528	0.781	4.551	2.555	-2.192	0.507	1.321	-0.517	-1.028	-1.826
BURTON_ADIPOGENESIS_5 BURTON_ADIPOGENESIS_5	-3.790	-1.843	-0.443	0.936	1.163	-1.843	0.413	3.050	1.998	0.561	-2.340
SESTO_RESPONSE_TO_UV_C0 SESTO_RESPONSE_TO_UV_C0	-2.671	-2.671	-0.334	2.739	2.031	-1.595	0.270	0.392	3.544	-0.909	-1.207
HAHTOLA_SEZARY_SYNDROM_UP HAHTOLA_SEZARY_SYNDROM_UP	-0.984	-2.331	0.540	4.188	2.867	-0.984	0.259	-0.506	1.194	-1.329	-3.059
KARLSSON_TGFB1_TARGETS_UP KARLSSON_TGFB1_TARGETS_UP	-2.509	-0.924	-0.366	1.272	4.433	-0.694	2.122	-0.510	1.037	-1.558	-3.145
RUIZ_TNC_TARGETS_DN RUIZ_TNC_TARGETS_DN	-1.054	-1.054	-0.465	0.495	1.718	-3.159	-0.465	4.948	2.298	-1.054	-2.079
PECE_MAMMARY_STEM_CELL_UP PECE_MAMMARY_STEM_CELL_UP	-1.559	-0.959	-0.553	0.426	0.565	-3.689	-0.292	2.495	2.833	1.880	-2.982
ZHANG_RESPONSE_TO_CANTHARIDIN_DN ZHANG_RESPONSE_TO_CANTHARIDIN_DN	-2.779	-1.302	0.238	0.388	0.818	-1.891	2.174	3.079	0.581	0.238	-2.771
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	-0.647	-0.647	-0.961	0.737	2.012	-2.903	0.519	3.867	0.997	-1.999	-1.992
CHUNG_BLISTER_CYTOTOXICITY_UP CHUNG_BLISTER_CYTOTOXICITY_UP	-0.940	-2.395	-0.396	1.144	1.635	-3.653	0.745	3.240	1.379	-0.539	-2.384
SEIDEN_ONCOGENESIS_BY_MET SEIDEN_ONCOGENESIS_BY_MET	-1.477	-1.999	1.856	0.736	3.018	-1.999	0.967	1.856	-0.771	-2.696	-0.766
SCHUHMACHER_MYC_TARGETS_UP SCHUHMACHER_MYC_TARGETS_UP	-2.363	-2.363	0.724	1.243	1.555	-1.707	0.353	3.136	0.965	-0.865	-2.355
WAKASUGI_HAVE_ZNF143_BINDING_SITES WAKASUGI_HAVE_ZNF143_BINDING_SITES	-2.239	-2.239	0.258	0.944	0.944	-2.239	3.053	0.664	1.274	-0.578	-1.426
RIZ_ERYTHROID_DIFFERENTIATION RIZ_ERYTHROID_DIFFERENTIATION	-0.633	-3.402	-0.911	2.578	2.179	-2.436	0.679	1.176	1.176	-0.911	-1.274
GAVIN_FOXP3_TARGETS_CLUSTER_P3 GAVIN_FOXP3_TARGETS_CLUSTER_P3	-0.337	-0.452	1.588	0.364	1.140	-4.669	-2.715	-1.852	2.401	-0.337	1.853
KAAB_FAILED_HEART_ATRIUM_DN KAAB_FAILED_HEART_ATRIUM_DN	-1.133	-2.698	-0.515	-0.275	4.702	-2.698	0.742	2.786	0.582	-0.381	-1.420
MORI_PLASMA_CELL_UP MORI_PLASMA_CELL_UP	-0.893	-1.397	-0.556	0.272	5.606	-0.332	0.272	1.706	0.455	-2.197	-2.191
FISCHER_G1_S_CELL_CYCLE FISCHER_G1_S_CELL_CYCLE	-0.586	-3.236	-0.264	2.636	1.610	-2.342	-0.351	1.843	1.610	-0.351	-3.220
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-0.751	-3.027	-0.418	1.325	2.454	-1.980	-1.252	0.710	2.789	1.097	-2.444
FARMER_BREAST_CANCER_CLUSTER_2 FARMER_BREAST_CANCER_CLUSTER_2	-1.367	-1.367	0.231	3.306	1.577	-0.733	-0.733	2.669	-0.385	-1.367	-1.364
ABRAMSON_INTERACT_WITH_AIRE ABRAMSON_INTERACT_WITH_AIRE	-1.824	-1.824	-0.373	1.798	5.388	-1.090	-0.373	0.430	0.684	-1.090	-1.086
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	1.300	0.254	0.661	-1.533	-1.186	-1.533	-1.957	-2.477	0.364	1.563	4.982
DITTMER_PTHLH_TARGETS_UP DITTMER_PTHLH_TARGETS_UP	-2.194	-1.310	-0.738	1.576	4.638	-2.809	0.344	0.837	1.057	-0.262	-1.696
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	-0.663	-0.663	-0.247	-0.663	-0.663	4.517	3.556	-0.663	-0.663	-0.663	-0.661
WHITFIELD_CELL_CYCLE_G1_S WHITFIELD_CELL_CYCLE_G1_S	-1.439	-2.831	0.361	1.492	2.056	-2.276	-0.352	2.056	2.056	-0.486	-2.266
KANG_DOXORUBICIN_RESISTANCE_UP KANG_DOXORUBICIN_RESISTANCE_UP	-2.239	-0.921	0.258	0.664	3.053	-2.239	0.944	1.652	0.435	-0.578	-2.233
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	1.738	-0.310	0.293	-1.549	-1.860	-2.624	-0.672	-0.528	-0.844	1.299	6.138
SASAKI_ADULT_T_CELL_LEUKEMIA SASAKI_ADULT_T_CELL_LEUKEMIA	-1.281	-1.926	-1.578	1.752	3.244	-2.331	0.445	1.752	1.076	0.445	-2.319
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	-0.422	-1.393	-0.422	4.988	2.012	-1.999	-0.422	-0.647	1.636	-0.961	-1.992
ALONSO_METASTASIS_UP ALONSO_METASTASIS_UP	-1.837	-3.061	-0.517	0.781	1.321	-1.837	2.555	2.850	1.124	-1.528	-0.821
LIU_SOX4_TARGETS_UP LIU_SOX4_TARGETS_UP	-1.252	-4.599	0.301	0.892	2.454	-2.455	-0.751	0.892	1.575	1.325	-0.745
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	3.690	0.870	0.262	0.262	-2.445	-0.661	-1.164	-1.928	-1.164	-0.661	4.135
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-1.540	-2.603	0.576	0.976	2.114	-2.009	2.114	0.419	1.789	-1.167	-2.000
KASLER_HDAC7_TARGETS_1_UP KASLER_HDAC7_TARGETS_1_UP	-1.770	-0.621	0.325	-0.621	0.543	-4.806	0.425	0.677	4.325	1.847	-1.195
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	-2.101	-1.424	-1.737	0.372	1.333	-3.012	-0.570	1.559	4.369	0.617	0.376
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	-0.642	-0.897	-0.897	4.990	2.298	-3.943	-0.897	0.301	0.301	0.301	-0.443
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	4.246	1.440	-0.744	-1.635	-2.605	0.445	-0.552	-2.072	-0.983	0.445	2.020
KAMMINGA_EZH2_TARGETS KAMMINGA_EZH2_TARGETS	-1.699	-1.699	-0.318	2.514	2.514	-0.991	0.783	1.129	-0.318	-0.991	-1.695
MOOTHA_VOXPHOS MOOTHA_VOXPHOS	-2.621	-1.420	0.404	0.576	1.297	-1.933	-0.338	3.140	1.297	0.576	-2.612
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	-0.566	-3.298	-0.412	1.410	5.567	-1.003	-1.299	0.578	0.432	0.578	-1.652
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	-2.253	-2.253	-1.612	1.055	3.338	-1.144	-0.541	0.396	2.875	-0.355	0.256
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	-1.354	-1.633	0.571	1.870	3.609	-2.732	-0.447	2.388	0.263	-0.725	-1.621
GROSS_HYPOXIA_VIA_HIF1A_UP GROSS_HYPOXIA_VIA_HIF1A_UP	-1.612	-2.253	-1.144	0.253	3.831	-0.797	1.680	2.046	0.396	-0.541	-1.605
KIM_ALL_DISORDERS_DURATION_CORR_DN KIM_ALL_DISORDERS_DURATION_CORR_DN	-1.731	-0.851	-0.851	-0.360	0.612	-2.145	0.469	5.729	1.173	0.777	-2.134
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-2.798	-2.247	0.504	1.522	2.750	-2.798	-0.641	0.660	1.796	-0.342	-0.338
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	1.479	3.154	0.775	-2.288	-2.913	2.076	-1.055	-1.055	-1.055	-0.291	0.314
RHODES_CANCER_META_SIGNATURE RHODES_CANCER_META_SIGNATURE	-0.810	-1.783	-0.329	0.651	2.808	-2.654	1.205	2.349	-0.527	-0.329	-1.777
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	-1.636	-1.318	1.133	2.428	3.080	-0.823	-2.455	0.347	1.591	-1.048	-1.309
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	-1.855	-1.855	-0.359	1.132	1.825	-0.860	1.132	2.231	0.846	-1.855	-1.848
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	-1.225	-1.990	0.571	0.571	3.014	-1.990	0.848	1.565	0.351	-1.225	-1.221
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	-0.260	-0.823	0.463	-1.318	-1.636	-1.318	-0.358	-2.012	0.599	1.851	5.940
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	-0.461	-3.439	0.677	2.130	2.452	-1.084	-1.084	1.830	0.677	-1.766	-1.076
MORI_PRE_BI_LYMPHOCYTE_UP MORI_PRE_BI_LYMPHOCYTE_UP	-3.360	-1.739	0.701	-0.412	2.635	-1.253	0.937	0.937	1.856	-0.888	-0.883
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	-1.117	-1.580	-0.341	1.387	2.096	-2.217	0.412	1.387	1.087	0.265	-3.144
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	-1.783	-0.810	-1.783	2.349	0.906	-2.654	0.440	1.205	1.546	0.440	-1.206
SMIRNOV_RESPONSE_TO_IR_6HR_UP SMIRNOV_RESPONSE_TO_IR_6HR_UP	-1.027	-1.027	-1.281	-0.366	0.722	-4.004	-0.486	2.594	3.244	1.076	-0.481
TIEN_INTESTINE_PROBIOTICS_6HR_UP TIEN_INTESTINE_PROBIOTICS_6HR_UP	-1.431	-2.239	-0.578	-0.578	3.602	-0.921	0.435	3.602	0.258	-0.578	-0.575
LY_AGING_OLD_DN LY_AGING_OLD_DN	-1.501	-1.501	-0.382	1.957	2.405	-2.322	-0.382	0.877	1.551	-0.382	-1.496
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	-1.397	-2.197	-0.556	2.616	1.706	-2.197	-0.332	1.319	0.980	-0.556	-0.553
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	-1.362	-1.362	-0.301	2.160	3.768	-4.142	-0.301	0.301	0.402	0.818	-0.869
ISHIDA_E2F_TARGETS ISHIDA_E2F_TARGETS	-0.865	-2.156	0.286	1.017	3.791	-1.362	-0.316	1.364	0.720	-1.362	-1.357
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	-2.322	-2.322	0.233	0.233	1.190	-1.501	0.877	1.957	1.190	0.612	-1.496
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-2.473	-1.308	1.439	2.946	2.523	0.467	0.313	-0.442	-0.934	-0.934	-1.796
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	-0.354	-0.468	1.264	-1.487	-1.807	-2.178	-1.211	0.577	-0.608	2.242	4.240
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	2.312	-1.420	-0.505	-0.505	0.782	-3.610	-0.505	0.782	-1.933	1.023	1.613
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	0.736	0.360	0.593	-0.728	-3.971	-1.681	-0.335	-1.132	-0.442	1.714	4.172
MIKKELSEN_MEF_LCP_WITH_H3K27ME3 MIKKELSEN_MEF_LCP_WITH_H3K27ME3	1.592	1.259	-0.438	-1.424	-1.424	3.786	-0.986	-1.424	-0.668	-1.424	1.266
WANG_TARGETS_OF_MLL_CBP_FUSION_DN WANG_TARGETS_OF_MLL_CBP_FUSION_DN	-0.676	-1.124	-0.676	0.958	2.204	-1.865	0.409	0.226	3.288	-0.676	-1.860
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-1.877	-0.464	0.260	2.078	4.061	-3.291	0.468	0.926	-0.347	-1.241	-0.776
IRITANI_MAD1_TARGETS_DN IRITANI_MAD1_TARGETS_DN	-1.907	-1.907	0.389	0.389	0.920	-1.907	0.920	2.640	0.920	-0.411	-1.153
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	-1.999	-1.393	-0.422	-1.393	3.867	-0.961	1.297	1.297	1.297	-0.647	-0.956
LAIHO_COLORECTAL_CANCER_SERRATED_UP LAIHO_COLORECTAL_CANCER_SERRATED_UP	-0.567	-4.775	0.610	0.610	0.795	-1.034	0.795	3.617	-0.281	-0.567	-1.027
SONG_TARGETS_OF_IE86_CMV_PROTEIN SONG_TARGETS_OF_IE86_CMV_PROTEIN	-1.466	-1.466	-0.949	2.015	1.601	-1.466	0.416	2.015	1.232	-1.466	-0.945
DAZARD_RESPONSE_TO_UV_SCC_UP DAZARD_RESPONSE_TO_UV_SCC_UP	-1.949	-3.296	-0.829	1.558	1.279	-1.487	0.447	2.199	1.279	0.312	-0.824
WHITFIELD_CELL_CYCLE_LITERATURE WHITFIELD_CELL_CYCLE_LITERATURE	-0.650	-1.824	-0.373	2.277	1.370	-1.824	0.239	0.998	1.370	-0.650	-1.819
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	1.140	2.708	0.945	-1.852	-3.901	-0.337	-0.767	-0.767	-1.221	1.140	1.149
BAKKER_FOXO3_TARGETS_UP BAKKER_FOXO3_TARGETS_UP	-0.578	-0.921	-0.921	0.664	2.076	-2.239	-0.348	0.435	4.191	-0.578	-1.426
BURTON_ADIPOGENESIS_6 BURTON_ADIPOGENESIS_6	-2.571	-1.011	0.649	0.797	0.649	-4.876	1.792	1.144	0.797	0.649	-0.806
IKEDA_MIR30_TARGETS_UP IKEDA_MIR30_TARGETS_UP	-1.055	-1.055	0.439	2.076	3.559	-3.714	-0.418	0.775	-0.291	0.311	-1.375
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	-1.061	-2.242	0.909	1.712	2.487	-1.883	0.750	0.909	0.909	-2.242	-1.287
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-1.540	-2.009	-0.312	3.240	0.762	-2.009	-0.312	0.762	1.789	0.576	-2.000
DAZARD_RESPONSE_TO_UV_SCC_DN DAZARD_RESPONSE_TO_UV_SCC_DN	-1.034	-1.760	-0.567	1.007	3.617	-2.878	1.801	1.007	-0.405	-0.405	-1.027
WHITFIELD_CELL_CYCLE_S WHITFIELD_CELL_CYCLE_S	-1.153	-2.228	-0.697	4.227	1.325	-1.452	0.433	1.325	0.725	-0.528	-1.797
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	0.595	2.768	-0.326	-1.901	-1.901	2.768	-0.489	-1.005	-1.901	-0.326	1.059
LIU_CMYB_TARGETS_UP LIU_CMYB_TARGETS_UP	-0.581	-1.490	0.276	1.379	0.965	-2.686	-1.201	1.162	3.784	0.276	-1.817
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	3.063	1.763	2.056	-1.439	-1.819	-1.439	-1.439	-0.867	-0.656	1.021	-0.348
TOOKER_GEMCITABINE_RESISTANCE_DN TOOKER_GEMCITABINE_RESISTANCE_DN	-1.558	-1.209	-0.366	0.486	1.815	-2.509	1.272	3.181	0.828	-1.209	-1.201
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	1.559	-2.775	0.950	-1.327	-0.867	-2.775	-0.687	-0.310	2.324	1.338	0.959
LANG_MYB_FAMILY_TARGETS LANG_MYB_FAMILY_TARGETS	-1.202	-1.202	0.302	0.928	3.110	-1.202	0.928	0.302	0.572	-1.202	-1.198
JOHNSTONE_PARVB_TARGETS_2_UP JOHNSTONE_PARVB_TARGETS_2_UP	0.348	-0.490	1.173	-0.258	-1.093	-4.832	-0.258	1.404	3.225	-1.093	-0.356
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	4.116	2.540	-1.508	-1.928	-0.885	-0.661	-0.661	-1.164	-0.343	-0.343	1.337
DE_YY1_TARGETS_DN DE_YY1_TARGETS_DN	-2.131	-1.176	2.789	1.692	2.789	-1.592	-0.279	-0.279	-0.418	-1.176	-0.602
DANG_REGULATED_BY_MYC_UP DANG_REGULATED_BY_MYC_UP	-1.332	-1.332	-0.240	1.062	0.560	-1.927	-0.390	3.505	1.728	-0.390	-1.920
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	-1.363	-1.363	1.029	-0.252	0.763	-1.963	0.357	1.681	1.681	0.539	-2.854
WONG_ENDMETRIUM_CANCER_DN WONG_ENDMETRIUM_CANCER_DN	0.772	4.814	0.243	-0.820	-0.559	0.558	-1.643	-2.290	-1.643	0.558	0.562
YAMAZAKI_TCEB3_TARGETS_DN YAMAZAKI_TCEB3_TARGETS_DN	-0.351	-1.373	-1.130	2.636	3.242	-1.654	0.559	1.009	0.559	-1.654	-1.642
APPIERTO_RESPONSE_TO_FENRETINIDE_DN APPIERTO_RESPONSE_TO_FENRETINIDE_DN	-0.837	-0.837	-0.837	0.301	1.055	-0.837	0.750	0.301	5.171	-0.837	-2.108
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	-1.284	-0.671	-1.284	2.878	1.241	-1.284	1.241	0.509	0.264	-0.341	-1.281
BYSTROEM_CORRELATED_WITH_IL5_DN BYSTROEM_CORRELATED_WITH_IL5_DN	-1.035	-1.035	-0.416	1.456	2.275	-1.035	1.844	1.112	-0.416	-1.035	-2.398
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	-0.792	-3.714	1.765	1.218	1.765	-1.383	0.311	1.218	0.439	-1.383	-0.786
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	-0.911	-0.911	-0.911	0.873	1.932	-0.911	-0.911	0.217	3.338	-0.406	-0.404
STEIN_ESRRA_TARGETS_DN STEIN_ESRRA_TARGETS_DN	-1.979	-1.514	-0.617	1.249	2.156	-3.334	0.432	1.827	0.301	-0.301	0.436
WENDT_COHESIN_TARGETS_UP WENDT_COHESIN_TARGETS_UP	-0.702	-1.326	1.647	-0.702	2.177	-1.326	0.247	1.647	0.480	-0.702	-1.322
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	-3.223	-1.572	1.177	0.526	0.815	-3.223	0.662	0.526	1.610	0.987	-0.508
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	-2.031	-1.259	-0.782	1.512	1.512	-1.259	-0.472	1.512	1.938	-0.472	-0.779
REICHERT_MITOSIS_LIN9_TARGETS REICHERT_MITOSIS_LIN9_TARGETS	-0.260	-1.119	-0.550	0.347	4.126	-0.550	-0.260	2.052	-0.550	-1.119	-1.116
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	-0.336	2.432	0.269	-1.741	-1.024	1.083	0.476	-1.741	-0.599	-1.024	1.935
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	-1.243	-1.243	-1.243	1.796	0.880	-0.640	1.301	0.880	0.880	-0.640	-1.240
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	0.598	0.412	-0.341	-1.580	-3.153	3.408	0.824	-1.117	-0.775	0.265	0.829
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	0.910	1.601	-0.365	-0.600	-2.280	1.232	0.416	-2.280	-1.466	0.245	1.238
MORI_MATURE_B_LYMPHOCYTE_DN MORI_MATURE_B_LYMPHOCYTE_DN	-2.180	-1.091	-0.327	0.276	1.426	-1.091	2.559	1.119	1.426	-1.549	-1.085
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	-0.486	-1.926	1.076	1.752	2.014	-1.281	0.574	1.282	-0.634	-0.486	-3.340
HONMA_DOCETAXEL_RESISTANCE HONMA_DOCETAXEL_RESISTANCE	-1.450	-1.450	0.403	-0.219	1.030	-0.796	-0.430	2.478	1.933	-0.430	-1.446
LENAOUR_DENDRITIC_CELL_MATURATION_DN LENAOUR_DENDRITIC_CELL_MATURATION_DN	-2.218	-2.218	0.273	1.553	1.067	-1.766	0.860	0.518	1.298	1.067	-1.756
PEART_HDAC_PROLIFERATION_CLUSTER_DN PEART_HDAC_PROLIFERATION_CLUSTER_DN	-1.424	-1.424	0.499	-0.276	1.259	-2.035	1.961	1.961	0.328	0.328	-2.028
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	1.928	0.651	0.274	-1.211	-1.783	-0.810	-0.329	-1.211	-1.211	0.440	3.845
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	-1.431	-1.431	-0.348	0.944	-0.348	-1.431	1.274	3.053	1.274	-0.578	-1.426
CHOI_ATL_STAGE_PREDICTOR CHOI_ATL_STAGE_PREDICTOR	-0.373	-1.824	-0.373	0.998	2.807	-1.824	0.430	0.684	0.430	0.239	-1.819
WILCOX_RESPONSE_TO_PROGESTERONE_UP WILCOX_RESPONSE_TO_PROGESTERONE_UP	-1.934	-0.775	0.500	0.644	2.542	-2.883	0.644	0.809	1.678	-1.566	-0.589
LAU_APOPTOSIS_CDKN2A_UP LAU_APOPTOSIS_CDKN2A_UP	-0.600	-0.600	0.245	5.358	0.910	-1.466	-0.949	-0.365	0.910	-0.600	-1.461
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	1.194	0.259	-0.714	-0.984	-1.329	0.946	0.540	-2.331	-1.768	0.728	3.297
YU_MYC_TARGETS_UP YU_MYC_TARGETS_UP	-1.057	-1.782	0.453	1.040	2.896	-1.782	0.453	0.715	0.453	-0.624	-1.053
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	-1.328	-2.114	-0.513	2.767	1.055	-0.837	0.301	1.412	0.750	-0.513	-1.323
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	-0.324	-0.787	-0.787	-0.787	0.609	-0.324	-0.787	1.613	3.856	-0.787	-0.323
PARK_APL_PATHOGENESIS_DN PARK_APL_PATHOGENESIS_DN	-1.990	-1.225	0.351	-0.256	-0.256	-1.225	1.180	-0.256	3.588	0.848	-1.221
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	-0.366	-1.578	1.076	-0.634	0.722	-4.004	-0.366	1.076	3.244	-0.366	-0.481
OHGUCHI_LIVER_HNF4A_TARGETS_DN OHGUCHI_LIVER_HNF4A_TARGETS_DN	2.295	1.076	0.336	-0.486	-2.331	0.445	-1.578	-1.027	-0.813	-0.813	3.262
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	1.998	1.695	-1.099	-1.099	-1.099	-0.312	-0.829	-0.829	-1.843	0.561	3.066
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-1.367	-1.367	-0.385	1.577	1.577	-1.367	0.453	1.130	0.453	0.231	-1.364
BURTON_ADIPOGENESIS_12 BURTON_ADIPOGENESIS_12	-0.702	-1.326	0.480	4.139	0.247	-1.326	0.793	0.480	-0.363	-1.326	-0.361
CAFFAREL_RESPONSE_TO_THC_DN CAFFAREL_RESPONSE_TO_THC_DN	-1.326	-0.363	-0.363	0.480	1.184	-1.326	0.793	1.184	1.647	-1.326	-1.322
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	3.198	0.901	-0.458	-0.761	-1.192	-0.595	-0.458	-1.784	-0.761	-0.761	3.559
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-0.567	-2.312	-0.424	2.307	0.526	-2.821	0.526	1.037	1.484	0.526	-1.511
GEORGES_CELL_CYCLE_MIR192_TARGETS GEORGES_CELL_CYCLE_MIR192_TARGETS	-1.152	-1.152	1.640	1.640	2.474	-1.152	-0.301	0.701	-0.301	-1.152	-1.706
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	-1.164	-1.164	-0.343	2.201	1.886	-3.087	-0.885	0.262	1.328	0.870	-0.656
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	-0.986	-1.424	0.499	1.961	1.961	-0.668	-0.438	1.259	-0.276	-0.276	-2.937
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	0.269	-2.021	1.484	-0.442	-0.572	-2.860	-1.681	0.896	0.593	1.074	2.242
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	0.782	-0.373	2.969	-1.167	-3.582	-0.265	-0.512	-1.167	-0.373	0.611	1.709
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	-0.520	-1.077	2.148	1.578	1.088	-0.520	0.684	-1.077	-0.241	-1.077	-1.074
LAIHO_COLORECTAL_CANCER_SERRATED_DN LAIHO_COLORECTAL_CANCER_SERRATED_DN	-1.901	-2.584	0.419	1.988	0.419	-1.901	0.595	1.644	0.595	0.419	-0.706
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	-0.837	-0.837	-0.301	-0.301	-0.837	-2.114	0.301	2.270	3.308	0.498	-0.833
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	-1.416	-2.247	-1.416	2.411	2.092	-0.641	0.372	1.522	0.372	-1.104	0.267
ISSAEVA_MLL2_TARGETS ISSAEVA_MLL2_TARGETS	1.004	1.004	0.728	-1.122	-0.738	0.315	-1.122	-2.529	-1.122	0.498	2.550
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	-1.580	-1.117	-0.775	0.824	1.724	-1.580	0.824	1.087	2.096	-0.523	-1.574
MMS_MOUSE_LYMPH_HIGH_4HRS_UP MMS_MOUSE_LYMPH_HIGH_4HRS_UP	-0.828	-1.492	-0.234	2.389	0.984	-1.492	-0.234	1.389	0.380	-0.234	-1.488
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	-0.957	-0.957	-0.328	-0.441	0.492	-3.228	-1.201	0.492	2.437	2.748	0.498
PODAR_RESPONSE_TO_ADAPHOSTIN_UP PODAR_RESPONSE_TO_ADAPHOSTIN_UP	-2.256	-2.256	-0.292	1.300	1.800	-1.474	-0.402	1.081	2.081	-0.402	-0.536
BURTON_ADIPOGENESIS_PEAK_AT_16HR BURTON_ADIPOGENESIS_PEAK_AT_16HR	-1.024	-1.741	0.269	0.476	0.476	-1.024	0.269	3.591	0.476	0.476	-1.736
YAGI_AML_SURVIVAL YAGI_AML_SURVIVAL	-0.943	-2.014	-0.710	1.780	2.083	-2.014	1.244	0.627	0.342	0.627	-1.575
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	-1.836	-1.836	-0.672	0.451	0.636	-0.958	0.301	3.807	1.726	-0.458	-0.667
WU_CELL_MIGRATION WU_CELL_MIGRATION	1.584	-0.302	-1.062	-0.674	-1.594	-0.851	0.968	-1.594	-1.062	1.361	3.300
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	1.032	0.816	-0.272	-0.393	-2.225	0.467	0.467	-2.843	-1.732	0.816	2.169
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	-2.031	-1.259	-0.271	1.512	-0.271	-0.782	1.512	1.137	1.512	-0.782	-1.255
BURTON_ADIPOGENESIS_10 BURTON_ADIPOGENESIS_10	-0.341	0.509	0.509	-0.341	-0.341	-1.284	-1.284	1.719	2.878	-1.284	-0.668
HU_GENOTOXIC_DAMAGE_4HR HU_GENOTOXIC_DAMAGE_4HR	-0.453	-1.492	-0.234	0.984	1.389	-1.492	1.859	0.984	-0.453	-0.453	-1.488
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	0.827	1.309	-0.810	-0.810	-3.258	0.827	1.053	-1.097	-1.460	0.461	1.603
EGUCHI_CELL_CYCLE_RB1_TARGETS EGUCHI_CELL_CYCLE_RB1_TARGETS	-0.911	-0.911	0.217	1.932	0.490	-0.911	-0.406	0.873	1.932	-0.911	-0.909
IVANOVSKA_MIR106B_TARGETS IVANOVSKA_MIR106B_TARGETS	-1.448	-1.448	-0.351	2.263	0.995	-2.658	0.256	0.256	2.263	-0.522	0.259
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-0.332	-0.556	-0.332	0.455	0.691	-2.197	0.691	0.455	3.135	-0.556	-2.191
PARK_HSC_AND_MULTIPOTENT_PROGENITORS PARK_HSC_AND_MULTIPOTENT_PROGENITORS	-0.676	0.226	0.226	0.654	1.320	-1.865	-0.392	2.204	0.958	-1.124	-1.860
FLORIO_HUMAN_NEOCORTEX FLORIO_HUMAN_NEOCORTEX	4.433	0.625	-0.702	-1.907	-0.702	-0.228	-0.702	-1.158	-0.411	0.625	0.628
SMID_BREAST_CANCER_LUMINAL_A_UP SMID_BREAST_CANCER_LUMINAL_A_UP	1.684	1.366	0.435	-1.868	-1.868	-0.313	-0.691	-0.981	-1.364	1.082	1.693
KAYO_AGING_MUSCLE_DN KAYO_AGING_MUSCLE_DN	-1.609	-2.573	0.788	1.470	2.045	-0.727	-0.388	0.990	0.990	-0.538	-1.601
BROWNE_HCMV_INFECTION_48HR_UP BROWNE_HCMV_INFECTION_48HR_UP	0.429	-2.662	-0.806	0.551	1.220	-1.529	0.849	2.460	0.326	0.691	-2.216
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	0.254	-1.057	-0.354	0.453	0.453	-1.057	1.040	1.861	1.423	-1.782	-1.777
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	0.301	0.301	0.432	1.002	-0.849	-1.143	-1.143	-0.849	-1.979	0.593	4.673
HU_ANGIOGENESIS_DN HU_ANGIOGENESIS_DN	-1.533	-0.477	-0.250	2.304	0.614	-0.860	2.304	0.359	-0.250	-1.533	-0.857
PLASARI_NFIC_TARGETS_BASAL_UP PLASARI_NFIC_TARGETS_BASAL_UP	1.432	0.607	0.978	-0.580	-1.160	-1.160	-0.580	-0.580	-1.160	-0.280	2.572
JAIN_NFKB_SIGNALING JAIN_NFKB_SIGNALING	-2.144	-1.064	0.445	1.466	0.878	-1.064	0.642	2.200	0.642	-1.517	-1.059
THEODOROU_MAMMARY_TUMORIGENESIS THEODOROU_MAMMARY_TUMORIGENESIS	0.264	-0.341	1.719	-1.284	0.264	0.509	-1.284	-1.284	-0.671	-0.341	2.887
KORKOLA_YOLK_SAC_TUMOR KORKOLA_YOLK_SAC_TUMOR	0.627	0.627	0.422	-0.344	-2.696	0.262	-1.241	0.262	-1.241	-0.344	3.760
DIRMEIER_LMP1_RESPONSE_EARLY DIRMEIER_LMP1_RESPONSE_EARLY	-1.712	-0.762	-0.762	-1.152	-0.301	-1.152	0.970	0.478	4.590	0.478	0.304
CUI_TCF21_TARGETS_UP CUI_TCF21_TARGETS_UP	2.389	-0.234	-0.828	-0.234	-1.492	-0.828	-0.234	-0.828	-0.453	-0.453	3.629
SENESE_HDAC2_TARGETS_UP SENESE_HDAC2_TARGETS_UP	-1.383	-0.418	-1.055	3.154	1.218	-0.792	-0.792	1.479	0.593	0.311	-2.278
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	1.286	0.594	-1.680	-1.680	0.290	-1.252	-0.659	-0.313	0.290	-0.461	4.421
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	-0.872	-3.697	0.428	1.759	2.951	-0.388	-0.518	0.877	-0.284	-0.872	-0.513
KARLSSON_TGFB1_TARGETS_DN KARLSSON_TGFB1_TARGETS_DN	-0.672	-3.090	1.738	1.510	1.299	-1.860	-1.045	0.386	0.386	1.104	-0.666
ZHAN_V2_LATE_DIFFERENTIATION_GENES ZHAN_V2_LATE_DIFFERENTIATION_GENES	-1.865	-1.124	0.226	0.226	0.958	-0.392	0.958	0.409	2.722	-0.392	-1.860
MILI_PSEUDOPODIA_CHEMOTAXIS_UP MILI_PSEUDOPODIA_CHEMOTAXIS_UP	-0.711	-1.392	1.644	1.331	1.052	-1.901	0.806	0.595	0.419	-2.584	-0.485
ZAMORA_NOS2_TARGETS_UP ZAMORA_NOS2_TARGETS_UP	-2.322	-0.622	0.397	0.397	0.877	-0.622	0.397	1.551	1.551	-0.382	-2.315
VANTVEER_BREAST_CANCER_METASTASIS_DN VANTVEER_BREAST_CANCER_METASTASIS_DN	-1.214	-1.595	-0.909	1.163	0.721	-0.909	-0.334	4.442	0.721	-0.479	-0.903
LUI_THYROID_CANCER_PAX8_PPARG_DN LUI_THYROID_CANCER_PAX8_PPARG_DN	-0.411	-1.907	-0.228	0.920	1.271	-1.158	0.625	-0.228	2.134	-0.411	-1.901
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	-1.117	-2.217	-0.523	0.598	2.096	-0.775	0.598	1.087	0.412	1.087	-2.209
VARELA_ZMPSTE24_TARGETS_UP VARELA_ZMPSTE24_TARGETS_UP	-1.057	-1.057	-0.624	1.423	0.453	-1.057	-0.624	1.861	1.040	1.040	-1.777
RASHI_RESPONSE_TO_IONIZING_RADIATION_2 RASHI_RESPONSE_TO_IONIZING_RADIATION_2	-0.388	-0.727	-2.043	2.368	0.610	-1.609	-1.609	1.746	1.470	-0.388	-0.270
TIAN_TNF_SIGNALING_NOT_VIA_NFKB TIAN_TNF_SIGNALING_NOT_VIA_NFKB	0.217	-0.911	-0.911	-0.911	0.490	-0.911	-0.911	0.217	2.594	1.356	0.493
ZHAN_MULTIPLE_MYELOMA_PR_UP ZHAN_MULTIPLE_MYELOMA_PR_UP	-1.158	-0.702	-0.702	0.920	1.271	-0.702	0.625	1.271	1.677	-1.907	-1.153
BROWNE_HCMV_INFECTION_18HR_UP BROWNE_HCMV_INFECTION_18HR_UP	-0.877	-1.362	0.402	1.191	2.753	-2.922	0.818	0.995	0.301	-0.405	-1.352
CAFFAREL_RESPONSE_TO_THC_UP CAFFAREL_RESPONSE_TO_THC_UP	-1.326	-1.326	-0.363	1.647	-0.363	-1.326	0.480	0.793	2.177	-0.702	0.248
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	-1.455	-0.689	0.688	-0.689	1.911	-1.455	0.688	1.549	1.223	-0.454	-2.064
CHANDRAN_METASTASIS_TOP50_UP CHANDRAN_METASTASIS_TOP50_UP	-0.925	-0.925	1.226	0.858	2.688	-0.925	0.320	-0.525	0.858	-1.616	-0.922
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	2.052	-0.550	0.644	-0.260	-1.119	-1.119	-0.550	2.675	-0.260	-0.260	-1.116
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	-0.412	-1.253	-1.253	-0.614	4.031	-0.888	-0.266	0.701	1.856	-0.266	-1.247
SCIBETTA_KDM5B_TARGETS_DN SCIBETTA_KDM5B_TARGETS_DN	-0.577	-1.675	-0.842	0.994	1.596	-2.326	0.538	1.949	0.748	-0.244	-1.192
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	0.884	0.421	0.884	-1.173	-1.173	-2.256	-1.173	-0.541	-0.402	3.400	1.090
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	-1.855	-1.271	1.132	0.250	2.231	-1.855	0.846	0.405	1.132	-0.566	-0.855
FOSTER_KDM1A_TARGETS_DN FOSTER_KDM1A_TARGETS_DN	-1.373	-2.342	-0.351	0.559	0.692	-1.654	0.842	0.559	2.636	1.193	-1.363
AIGNER_ZEB1_TARGETS AIGNER_ZEB1_TARGETS	1.030	0.680	-0.430	0.680	-1.450	-0.219	-1.450	-1.450	-0.430	-0.219	2.486
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	-0.351	-0.739	0.842	4.261	1.193	-2.760	-0.458	-0.458	0.341	-1.130	-0.580
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	-1.090	-0.373	-0.650	0.239	0.684	-1.824	-1.090	4.009	0.430	0.684	-0.371
YAMAZAKI_TCEB3_TARGETS_UP YAMAZAKI_TCEB3_TARGETS_UP	-2.277	0.601	-0.464	0.601	-0.347	-2.745	-1.534	1.560	1.330	1.118	0.607
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	1.813	1.074	0.693	-2.485	-2.485	1.545	-0.430	-0.430	-0.996	0.693	-0.425
GENTILE_UV_RESPONSE_CLUSTER_D4 GENTILE_UV_RESPONSE_CLUSTER_D4	-0.578	-1.431	0.435	1.274	3.602	-0.578	0.664	-0.348	0.258	-1.431	-1.426
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	-1.621	-2.882	0.456	-0.432	1.985	-0.875	-0.624	1.653	0.840	0.840	-0.429
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	-0.732	-1.517	0.445	0.445	0.288	-3.070	0.642	1.153	1.815	0.642	-1.059
WEBER_METHYLATED_HCP_IN_SPERM_DN WEBER_METHYLATED_HCP_IN_SPERM_DN	-0.300	1.365	-0.610	-0.300	-1.202	1.365	-0.610	-1.202	-1.202	0.572	1.883
AMIT_EGF_RESPONSE_480_HELA AMIT_EGF_RESPONSE_480_HELA	0.276	-1.201	0.374	0.276	0.492	-5.574	0.276	1.162	0.492	0.492	1.172
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	-0.506	-0.506	0.276	0.428	0.850	-3.111	-0.753	3.004	1.119	-0.506	-0.749
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	-1.907	-0.411	-0.411	1.677	2.134	-0.702	-0.411	0.625	-0.228	0.625	-1.901
HOQUE_METHYLATED_IN_CANCER HOQUE_METHYLATED_IN_CANCER	0.877	1.957	-0.977	-0.622	-2.322	-0.977	0.397	-0.977	0.233	0.397	1.965
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-1.114	-1.114	0.370	-0.327	0.479	-3.939	0.751	0.914	1.992	1.293	-0.708
TAKAO_RESPONSE_TO_UVB_RADIATION_UP TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-1.029	-1.420	0.267	0.782	0.267	-0.731	0.267	0.576	3.596	0.576	-2.612
MAYBURD_RESPONSE_TO_L663536_DN MAYBURD_RESPONSE_TO_L663536_DN	-0.949	-0.949	0.910	1.601	2.015	-1.466	-0.600	0.910	0.637	-1.466	-0.945
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	2.870	0.706	-0.277	-1.951	-1.951	-0.277	-0.648	-1.045	-0.648	0.706	1.996
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	-0.574	-1.699	-0.318	1.997	0.501	-0.991	1.997	0.285	0.501	-0.318	-1.695
MADAN_DPPA4_TARGETS MADAN_DPPA4_TARGETS	0.756	2.153	1.039	-1.093	-1.093	-0.274	-0.715	-0.715	-2.488	0.756	0.760
PEART_HDAC_PROLIFERATION_CLUSTER_UP PEART_HDAC_PROLIFERATION_CLUSTER_UP	-2.197	-0.893	-0.332	1.706	0.455	-0.893	-0.332	1.319	2.139	-0.556	-0.888
GUTIERREZ_MULTIPLE_MYELOMA_UP GUTIERREZ_MULTIPLE_MYELOMA_UP	-1.492	-0.828	0.984	-0.234	1.859	-0.828	-0.453	1.389	0.984	-1.492	-0.451
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	-2.156	-0.535	0.476	-0.535	2.203	-0.865	-0.316	2.690	0.476	-0.865	-0.532
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	-0.234	-1.492	-0.828	0.984	0.646	-1.492	0.646	1.389	0.984	-0.234	-1.488
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	0.615	0.615	0.615	-0.981	-1.868	-0.313	-0.313	-2.547	-0.691	2.034	1.693
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	-1.097	-2.500	-0.280	0.461	0.827	-1.097	0.827	1.593	1.593	0.461	-1.910
GROSS_HYPOXIA_VIA_ELK3_DN GROSS_HYPOXIA_VIA_ELK3_DN	-1.613	-1.613	1.378	0.357	-0.348	-1.030	0.954	0.773	1.882	0.773	-2.414
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	-1.739	-1.253	0.701	0.701	1.856	-1.253	-0.412	2.635	0.339	-0.412	-1.247
WEI_MIR34A_TARGETS WEI_MIR34A_TARGETS	-0.667	-2.667	-0.503	1.150	2.187	-1.113	-0.371	-0.371	2.828	-0.503	-0.498
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	0.339	1.278	0.584	-0.500	-1.575	1.278	-0.893	-1.575	-0.893	-0.266	1.727
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	1.432	1.962	-0.280	-1.160	-1.160	1.432	-0.580	-1.160	0.324	-0.580	-0.278
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	-1.606	-0.434	-0.260	1.791	1.791	-1.606	0.784	1.075	-0.260	-0.691	-1.601
DOANE_BREAST_CANCER_ESR1_UP DOANE_BREAST_CANCER_ESR1_UP	2.328	-0.930	0.261	-0.346	-0.493	-0.930	0.261	-2.705	-0.685	0.701	2.704
LEE_METASTASIS_AND_RNA_PROCESSING_UP LEE_METASTASIS_AND_RNA_PROCESSING_UP	-0.663	-0.247	-0.663	2.696	0.762	-0.663	1.292	0.362	-0.663	-0.663	-0.661
FAELT_B_CLL_WITH_VH3_21_UP FAELT_B_CLL_WITH_VH3_21_UP	-1.124	-1.865	-0.392	1.736	0.654	-1.124	0.226	0.958	1.736	0.226	-1.120
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	-0.431	-1.191	-0.242	0.597	2.561	-1.191	1.225	-0.242	0.883	-0.729	-1.943
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	0.858	1.226	-0.283	-1.616	-1.616	-0.283	0.320	-1.616	0.320	0.320	1.662
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	-0.332	-2.197	0.455	0.272	-0.893	-2.197	0.455	1.319	1.319	0.980	-0.330
ZHU_CMV_24_HR_UP ZHU_CMV_24_HR_UP	-0.427	-1.771	-0.633	2.179	0.679	-2.436	-0.278	1.812	0.909	-0.427	-0.629
CASTELLANO_NRAS_TARGETS_UP CASTELLANO_NRAS_TARGETS_UP	0.481	-0.288	0.481	-2.071	0.481	-2.986	-0.454	0.481	-0.454	0.688	2.320
LUI_THYROID_CANCER_PAX8_PPARG_UP LUI_THYROID_CANCER_PAX8_PPARG_UP	-0.702	-1.158	2.640	1.271	0.389	-1.907	-1.158	0.389	0.625	0.389	-0.699
GENTILE_UV_RESPONSE_CLUSTER_D5 GENTILE_UV_RESPONSE_CLUSTER_D5	-0.430	-1.450	-0.796	1.030	3.081	-0.796	-0.219	1.449	-0.219	-0.796	-0.793
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	-1.136	-2.076	0.284	1.832	2.993	-1.403	0.382	0.785	-0.718	0.497	-0.902
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	-0.313	-1.868	0.289	4.232	0.831	-0.691	-0.981	0.831	-0.473	0.289	-1.357
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN	0.822	3.883	0.517	-1.446	0.395	-1.162	-1.779	-1.446	0.292	0.660	0.296
RAHMAN_TP53_TARGETS_PHOSPHORYLATED RAHMAN_TP53_TARGETS_PHOSPHORYLATED	-0.828	-0.828	-0.828	1.521	2.148	-0.828	0.566	0.566	0.256	-0.351	-0.826
MELLMAN_TUT1_TARGETS_UP MELLMAN_TUT1_TARGETS_UP	-0.828	-0.828	0.256	0.566	2.148	-0.828	1.521	-0.351	0.566	-0.828	-0.826
LIU_NASOPHARYNGEAL_CARCINOMA LIU_NASOPHARYNGEAL_CARCINOMA	-2.035	-0.986	0.499	1.592	2.366	-2.035	0.499	0.328	0.499	-0.668	-0.435
CARD_MIR302A_TARGETS CARD_MIR302A_TARGETS	-0.355	0.396	-0.541	0.798	2.444	-1.144	-3.194	0.253	1.350	-0.541	-0.352
ROSS_AML_WITH_MLL_FUSIONS ROSS_AML_WITH_MLL_FUSIONS	-1.225	-1.225	0.724	3.136	-0.255	-1.225	-0.865	1.243	1.243	-0.596	-0.860
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-0.729	-1.191	-0.242	0.883	0.883	-1.948	0.883	2.561	-0.242	-0.431	-1.187
CERVERA_SDHB_TARGETS_2 CERVERA_SDHB_TARGETS_2	0.610	1.246	-0.281	-0.774	-1.760	-0.774	-0.774	-0.567	-1.358	1.007	3.634
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	-1.077	-1.077	-0.241	0.371	0.371	-1.077	0.371	2.148	1.578	-0.241	-1.074
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11 GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	0.459	-1.748	0.288	1.244	-0.315	-1.181	-0.315	0.675	1.593	-2.613	0.680
SEIDEN_MET_SIGNALING SEIDEN_MET_SIGNALING	0.256	-0.828	0.991	0.991	2.148	-0.828	-0.828	0.566	-0.351	-0.828	-0.826
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	-0.668	-2.405	0.564	-0.416	1.844	-1.035	-0.416	0.362	2.747	-0.416	-0.414
ODONNELL_TFRC_TARGETS_DN ODONNELL_TFRC_TARGETS_DN	-1.016	-0.784	-0.784	3.051	2.375	-1.016	-0.320	0.852	0.391	-0.594	-1.623
BOYLAN_MULTIPLE_MYELOMA_C_D_UP BOYLAN_MULTIPLE_MYELOMA_C_D_UP	-1.583	-0.566	0.551	1.575	2.789	-1.583	0.551	1.097	-0.751	-0.977	-0.970
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-0.659	-1.528	0.507	1.124	-0.302	-2.597	0.944	0.944	2.012	0.396	-1.826
YAGI_AML_WITH_T_9_11_TRANSLOCATION YAGI_AML_WITH_T_9_11_TRANSLOCATION	-1.392	-2.218	1.067	0.518	3.160	-1.392	-0.625	1.067	0.273	-0.331	-0.328
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	-1.016	-2.034	-0.594	1.781	1.051	-2.034	0.522	2.068	0.522	-0.784	0.286
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	-1.741	-1.024	1.477	1.083	1.083	-1.024	0.269	1.477	-1.024	-0.336	-0.596
BILANGES_RAPAMYCIN_SENSITIVE_GENES BILANGES_RAPAMYCIN_SENSITIVE_GENES	-0.477	0.359	-0.860	1.332	2.876	-1.533	0.359	-0.250	0.359	-0.477	-1.529
WIERENGA_PML_INTERACTOME WIERENGA_PML_INTERACTOME	-0.624	-1.057	-0.624	1.423	2.353	-1.057	-0.624	0.453	1.861	-0.624	-1.053
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	0.715	0.715	0.254	-1.057	-0.624	0.715	-0.354	-1.782	-1.782	0.715	1.869
DER_IFN_BETA_RESPONSE_UP DER_IFN_BETA_RESPONSE_UP	-1.434	-1.888	0.849	1.340	2.289	-1.888	-0.398	0.849	-0.398	0.476	-0.564
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	-1.990	-0.755	0.571	1.180	1.180	-1.990	0.351	-0.256	0.351	1.180	-0.752
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	0.576	-0.338	1.023	0.782	-1.029	-1.933	-1.420	1.023	1.604	0.576	-1.926
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	-1.798	-3.107	0.707	1.164	0.921	-0.733	-0.521	0.921	0.707	0.921	-0.728
KANG_IMMORTALIZED_BY_TERT_DN KANG_IMMORTALIZED_BY_TERT_DN	1.405	2.028	-0.373	-1.029	-0.250	0.359	-1.029	-1.381	-0.752	-1.381	2.393
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-1.707	-0.397	-0.397	1.555	-0.255	-2.363	-0.596	0.353	2.282	1.243	-0.592
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-1.367	-1.659	1.094	0.751	0.914	-1.367	-1.659	-0.327	2.842	0.479	0.281
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	-1.036	-0.222	0.398	1.658	1.149	-1.036	-0.491	1.149	0.398	-1.036	-1.033
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	-1.310	-1.704	-0.992	1.303	1.303	-2.194	0.837	1.303	0.481	0.645	-0.532
KOBAYASHI_EGFR_SIGNALING_24HR_UP KOBAYASHI_EGFR_SIGNALING_24HR_UP	0.667	0.492	-0.553	3.109	-0.771	-3.183	-1.051	-0.553	0.346	0.667	0.496
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	-1.815	-1.815	2.368	0.959	0.301	-1.815	-0.301	0.959	0.959	0.301	-0.593
MIKKELSEN_ES_ICP_WITH_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K27ME3	1.928	0.476	-0.599	-1.024	-1.741	2.432	0.269	-0.599	-0.336	-1.024	0.479
BOUDOUKHA_BOUND_BY_IGF2BP2 BOUDOUKHA_BOUND_BY_IGF2BP2	-1.514	-1.979	-0.301	0.593	2.892	-1.514	0.783	0.432	1.002	0.301	-0.843
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	-0.828	-0.828	0.991	-0.828	2.148	-0.828	0.566	0.566	0.566	-0.351	-0.826
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	1.336	1.336	-0.406	-1.963	-1.963	2.484	-0.252	-0.406	-0.406	-0.252	-0.622
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	-1.741	-1.741	0.476	0.476	0.269	-0.336	1.928	1.083	0.749	-0.599	-1.020
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	-1.077	-0.520	0.684	-1.077	0.371	-0.520	0.684	0.684	2.792	-0.520	-1.074
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	-1.699	-0.991	0.285	0.285	1.997	-0.991	0.501	1.997	0.501	-0.574	-0.987
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	-0.545	-1.691	-0.415	-0.310	-0.704	-2.051	-0.415	0.509	4.089	0.976	0.652
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	-0.733	-0.385	0.231	2.092	2.092	-1.367	-0.733	0.453	0.453	-0.385	-1.364
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	-1.872	-1.120	0.716	2.630	1.661	-1.120	0.716	0.281	-0.456	0.281	-1.449
BILBAN_B_CLL_LPL_DN BILBAN_B_CLL_LPL_DN	-0.599	-1.741	0.269	1.083	1.477	-1.741	-1.024	0.749	1.083	-0.336	0.271
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	-0.953	-0.953	0.199	1.282	1.282	-0.953	0.821	-0.953	1.282	-0.434	-0.432
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	-1.580	-1.117	0.412	0.824	1.724	-1.117	-0.341	0.598	1.087	0.824	-2.209
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-1.077	-1.477	0.246	-0.364	2.214	-0.538	0.736	0.736	1.231	0.376	-2.686
THILLAINADESAN_ZNF217_TARGETS_UP THILLAINADESAN_ZNF217_TARGETS_UP	-1.699	0.285	0.783	1.129	0.501	-1.699	0.285	-0.318	1.997	-0.574	-0.987
SMITH_LIVER_CANCER SMITH_LIVER_CANCER	-1.225	-0.256	-0.256	0.571	0.848	-1.990	2.485	-0.755	0.571	0.571	-1.221
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	-0.315	-0.786	-0.315	-0.786	0.459	-2.613	0.459	1.244	0.938	1.982	-1.176
GAVIN_FOXP3_TARGETS_CLUSTER_P6 GAVIN_FOXP3_TARGETS_CLUSTER_P6	-0.812	-1.534	0.349	0.914	1.455	-2.770	0.693	0.914	1.168	-0.572	-0.807
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	0.426	0.772	-0.994	-0.994	-0.994	0.426	2.357	-0.994	-0.462	-0.204	0.775
BHATTACHARYA_EMBRYONIC_STEM_CELL BHATTACHARYA_EMBRYONIC_STEM_CELL	-1.336	-1.836	0.856	-0.458	2.886	-0.301	0.301	1.402	0.451	-1.336	-0.667
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	-0.340	-2.089	0.495	0.814	-0.465	-0.817	-0.623	2.960	0.814	0.814	-2.079
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	-1.739	-1.739	0.937	0.502	0.701	-0.614	-0.266	2.230	0.937	-0.266	-1.732
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	-0.610	-0.610	0.302	1.365	0.928	-0.610	0.302	2.460	-1.202	-0.610	-1.198
LEE_AGING_NEOCORTEX_UP LEE_AGING_NEOCORTEX_UP	0.578	-2.253	-1.144	1.350	-0.541	-0.797	1.680	-1.144	1.680	0.253	0.256
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	-0.860	-1.271	0.846	2.231	1.458	-0.860	-0.566	1.132	-0.359	-0.359	-1.848
HARRIS_BRAIN_CANCER_PROGENITORS HARRIS_BRAIN_CANCER_PROGENITORS	1.040	0.453	-0.354	-1.782	-1.057	-0.354	1.861	-1.057	-0.624	-0.354	1.869
ZHOU_TNF_SIGNALING_30MIN ZHOU_TNF_SIGNALING_30MIN	-1.328	-0.513	-1.328	-0.513	0.301	-1.328	0.498	0.301	3.308	1.412	-0.299
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	1.900	-1.536	-0.645	0.845	-0.645	-1.006	-0.235	-0.399	-1.536	0.845	1.908
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	1.039	0.756	-0.274	-1.093	-0.715	0.519	-1.093	-1.093	-1.093	-0.274	3.641
LEIN_CHOROID_PLEXUS_MARKERS LEIN_CHOROID_PLEXUS_MARKERS	4.246	1.027	-0.424	-1.120	-0.829	-0.829	-0.424	-1.120	-0.829	0.312	1.034
JI_RESPONSE_TO_FSH_DN JI_RESPONSE_TO_FSH_DN	-0.893	-2.197	0.272	2.616	1.319	-1.397	-0.332	0.455	0.455	-0.332	-0.330
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	-0.702	-0.702	-0.363	0.793	-0.702	-1.326	-0.702	0.793	1.184	2.771	-0.699
ELVIDGE_HIF1A_TARGETS_UP ELVIDGE_HIF1A_TARGETS_UP	-1.927	-1.927	0.790	0.560	-0.240	-0.390	1.062	1.728	1.062	-0.910	-0.905
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	-0.925	-1.616	-0.283	1.226	-0.525	-1.616	0.858	0.555	1.656	0.555	-0.522
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	-0.228	-0.702	3.791	-1.158	-1.907	0.625	0.389	-0.702	-0.228	-0.228	0.391
GOLUB_ALL_VS_AML_DN GOLUB_ALL_VS_AML_DN	-0.953	-0.434	0.199	0.199	-0.434	-0.953	1.282	-0.434	0.457	3.188	-0.950
ZHU_CMV_ALL_UP ZHU_CMV_ALL_UP	0.290	-2.009	-0.451	2.114	0.419	-2.603	-0.312	1.789	0.576	0.290	-0.629
GENTILE_RESPONSE_CLUSTER_D3 GENTILE_RESPONSE_CLUSTER_D3	-0.893	-1.397	-0.556	2.139	0.980	-0.893	0.272	2.139	0.272	-0.332	-1.392
CHEOK_RESPONSE_TO_HD_MTX_DN CHEOK_RESPONSE_TO_HD_MTX_DN	-0.406	-0.911	0.217	1.356	1.932	-0.911	0.490	-0.406	0.873	-0.911	-0.909
CROMER_TUMORIGENESIS_UP CROMER_TUMORIGENESIS_UP	0.564	0.814	0.814	-1.035	-2.405	0.362	-0.416	-1.035	-1.035	1.112	1.463
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	-0.738	-2.529	1.004	-0.738	1.689	-0.738	0.498	1.004	0.728	0.315	-1.117
CHUNG_BLISTER_CYTOTOXICITY_DN CHUNG_BLISTER_CYTOTOXICITY_DN	-2.073	-1.294	0.781	1.877	0.781	-0.810	0.317	0.781	0.317	0.317	-1.289
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	-1.119	-0.260	-0.260	-0.550	4.126	-0.550	-0.550	0.347	0.644	0.347	-1.116
LUI_THYROID_CANCER_CLUSTER_3 LUI_THYROID_CANCER_CLUSTER_3	-0.580	-1.160	0.324	0.607	0.324	-0.580	0.324	-0.280	3.971	-0.580	-1.157
MACAEVA_PBMC_RESPONSE_TO_IR MACAEVA_PBMC_RESPONSE_TO_IR	-0.810	-2.500	-1.460	0.323	1.053	-0.411	-0.411	1.309	1.593	1.309	-0.804
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	1.912	-0.278	0.429	-1.529	-0.373	-2.662	-1.010	-0.491	0.849	0.326	2.192
APRELIKOVA_BRCA1_TARGETS APRELIKOVA_BRCA1_TARGETS	0.351	0.351	-1.990	2.001	-0.256	-0.755	-0.256	0.351	1.180	-1.990	0.354
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	0.500	-0.354	-0.496	-1.957	-0.354	-1.533	0.849	-0.496	1.300	-0.905	3.248
SU_KIDNEY SU_KIDNEY	2.069	0.396	-0.223	-0.621	-0.621	0.823	-0.621	-0.621	-0.621	1.385	-0.620
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	-1.090	-0.650	0.239	0.430	0.684	-0.650	-0.373	1.798	2.277	-0.650	-1.819
VANTVEER_BREAST_CANCER_BRCA1_UP VANTVEER_BREAST_CANCER_BRCA1_UP	-1.409	-1.409	-0.407	0.427	2.571	-0.407	1.512	0.427	-0.407	0.216	-0.762
HELLER_SILENCED_BY_METHYLATION_DN HELLER_SILENCED_BY_METHYLATION_DN	0.290	-1.540	-0.634	-0.634	-0.869	-1.540	-0.451	1.491	2.114	2.114	-0.309
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	-1.592	-2.131	-0.606	1.385	2.029	-0.279	-0.279	1.385	0.324	-1.176	0.327
WONG_PROTEASOME_GENE_MODULE WONG_PROTEASOME_GENE_MODULE	-1.294	-1.294	-0.492	1.461	0.781	-1.294	0.521	1.877	0.521	0.317	-1.289
UEDA_PERIFERAL_CLOCK UEDA_PERIFERAL_CLOCK	-0.662	-1.321	-0.845	1.236	0.690	-2.863	0.318	-0.285	2.830	0.547	-0.281
LIU_COMMON_CANCER_GENES LIU_COMMON_CANCER_GENES	0.440	-1.211	0.651	1.928	1.546	-2.654	0.274	-0.329	0.274	-0.810	-0.524
TAKAO_RESPONSE_TO_UVB_RADIATION_DN TAKAO_RESPONSE_TO_UVB_RADIATION_DN	-1.739	-0.336	0.269	1.507	1.507	-1.739	0.398	1.507	0.398	-0.491	-1.731
PECE_MAMMARY_STEM_CELL_DN PECE_MAMMARY_STEM_CELL_DN	-0.360	-0.851	1.404	1.173	1.656	-3.226	-0.490	0.777	0.469	-0.851	-0.845
NGUYEN_NOTCH1_TARGETS_DN NGUYEN_NOTCH1_TARGETS_DN	-0.289	-2.473	-0.289	0.467	0.467	-2.473	0.883	2.130	-0.289	0.657	-0.439
ROSS_AML_WITH_PML_RARA_FUSION ROSS_AML_WITH_PML_RARA_FUSION	0.502	-0.888	-0.266	-0.614	0.502	-2.400	-0.412	0.339	2.635	1.516	-1.247
KATSANOU_ELAVL1_TARGETS_UP KATSANOU_ELAVL1_TARGETS_UP	1.169	0.976	0.292	-0.704	-2.051	-0.310	-1.382	-1.382	1.861	-0.545	1.624
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	1.565	1.899	0.390	0.557	-1.966	-0.351	0.256	-1.448	-1.966	0.256	0.562
COATES_MACROPHAGE_M1_VS_M2_UP COATES_MACROPHAGE_M1_VS_M2_UP	1.052	-0.711	0.806	0.278	0.419	-3.568	-1.005	0.806	1.052	-0.711	0.423
NAKAMURA_ADIPOGENESIS_LATE_UP NAKAMURA_ADIPOGENESIS_LATE_UP	-1.709	-0.940	-0.476	0.997	1.859	-2.264	0.279	1.859	0.412	-0.324	-0.321
BROWN_MYELOID_CELL_DEVELOPMENT_DN BROWN_MYELOID_CELL_DEVELOPMENT_DN	-0.292	-0.566	-1.299	-0.292	3.362	-2.101	0.311	0.749	1.410	-0.566	-0.755
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	-1.064	-0.314	-0.732	1.153	0.878	-2.144	1.466	0.642	1.153	-0.488	-1.511
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	1.604	1.604	0.782	-0.338	-1.933	-0.505	-0.731	-1.933	-0.505	-0.338	1.305
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	-0.486	-2.276	0.255	0.255	0.490	-2.276	1.763	1.763	1.021	-0.486	-0.482
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	-0.234	2.389	-0.828	-1.492	-1.492	0.984	-0.234	-0.453	0.646	0.646	-0.451
VANTVEER_BREAST_CANCER_ESR1_UP VANTVEER_BREAST_CANCER_ESR1_UP	-0.682	-0.515	0.582	0.445	-0.275	-4.910	0.582	0.445	1.597	0.329	0.449
FIRESTEIN_PROLIFERATION FIRESTEIN_PROLIFERATION	-1.877	0.260	1.560	0.754	0.601	-3.936	0.355	-0.347	0.355	0.355	0.761
RICKMAN_HEAD_AND_NECK_CANCER_E RICKMAN_HEAD_AND_NECK_CANCER_E	0.404	2.312	1.023	-1.933	-0.731	1.297	-0.505	-1.933	-0.505	-0.338	0.408
GALE_APL_WITH_FLT3_MUTATED_UP GALE_APL_WITH_FLT3_MUTATED_UP	-1.064	-1.606	1.075	0.784	1.411	-1.064	-0.260	1.075	0.784	-0.434	-1.601
THUM_MIR21_TARGETS_HEART_DISEASE_UP THUM_MIR21_TARGETS_HEART_DISEASE_UP	1.128	-0.298	-0.298	-0.746	-0.298	-0.746	-0.746	0.304	-0.746	0.304	3.190
TIEN_INTESTINE_PROBIOTICS_2HR_DN TIEN_INTESTINE_PROBIOTICS_2HR_DN	-0.538	-1.999	-0.538	1.231	1.528	-1.999	0.736	0.967	0.539	0.376	-1.072
BROWNE_HCMV_INFECTION_20HR_DN BROWNE_HCMV_INFECTION_20HR_DN	-1.407	-1.407	3.109	-0.553	0.872	-1.051	-1.051	-0.385	0.667	0.667	0.672
KAPOSI_LIVER_CANCER_MET_UP KAPOSI_LIVER_CANCER_MET_UP	-0.746	-0.746	-0.298	0.304	1.128	-0.746	0.304	1.713	-0.746	1.128	-0.744
YAGI_AML_FAB_MARKERS YAGI_AML_FAB_MARKERS	-0.528	0.293	-0.408	-0.672	-0.310	-3.623	0.386	2.521	1.738	0.293	-0.403
ONDER_CDH1_TARGETS_1_DN ONDER_CDH1_TARGETS_1_DN	-1.063	-0.285	0.423	2.227	1.236	0.318	-0.510	-0.845	0.690	0.423	-3.404
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	-0.778	0.301	-0.424	0.301	0.731	-2.669	-0.778	0.301	3.311	0.923	-0.772
FARMER_BREAST_CANCER_CLUSTER_4 FARMER_BREAST_CANCER_CLUSTER_4	1.057	-0.324	1.057	-0.324	-0.324	0.279	-0.787	-0.787	-0.787	-0.787	2.275
KIM_WT1_TARGETS_12HR_UP KIM_WT1_TARGETS_12HR_UP	1.534	-0.798	1.097	0.738	-0.621	-2.304	-1.556	-1.010	0.345	1.306	0.745
